Philip Morris International's stock surged 5.03% during intraday trading on Wednesday, reflecting significant investor optimism.

The sharp rise follows the company's release of better-than-expected second-quarter results, with adjusted earnings per share of $2.20 beating the IBES estimate of $2.04 and net revenue of $11.20 billion surpassing the consensus forecast of $10.63 billion. Concurrently, a major regulatory catalyst emerged as the U.S. Food and Drug Administration issued Modified Risk Tobacco Product orders for 20 variants of the company's ZYN nicotine pouches earlier this month, authorizing reduced-risk marketing claims.

Positive analyst sentiment also contributed to the bullish momentum, with BTIG initiating coverage on the stock with a Buy rating and a $216 price target. The company noted that consumer demand for its products has remained resilient despite geopolitical tensions, and it is ramping up investment to grow its smoke-free ZYN business.